EUA
InspectIR COVID-19 Breathalyzer
FDA Emergency Use Authorization · InspectIR Systems LLC · Apr 14, 2022
Key facts
| Product | InspectIR COVID-19 Breathalyzer |
|---|---|
| Company | InspectIR Systems LLC |
| Product type | Rapid gas chromatography-mass spectrometry (GC-MS), Five Volatile Organic Compounds (VOCs), Screening |
| Date | Apr 14, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: